
Apoptosis
Los inhibidores de la apoptosis son compuestos que previenen o retrasan el proceso de muerte celular programada, conocido como apoptosis. Estos inhibidores son vitales para estudiar los mecanismos de supervivencia celular y se utilizan para investigar enfermedades donde la apoptosis está desregulada, como el cáncer, los trastornos neurodegenerativos y las enfermedades autoinmunes. Al modular la apoptosis, estos inhibidores pueden ayudar en el desarrollo de terapias dirigidas a controlar la muerte celular. En CymitQuimica, ofrecemos una amplia selección de inhibidores de la apoptosis de alta calidad para apoyar su investigación en biología celular, oncología y campos relacionados.
Subcategorías de "Apoptosis"
- ASK(6 productos)
- BCL(11 productos)
- Caspasa(125 productos)
- FOXO1(3 productos)
- IAP(66 productos)
- Mdm2(12 productos)
- PD-1 / PD-L1(125 productos)
- PDK(9 productos)
- PERK(25 productos)
- Serina / treonina quinasa(15 productos)
- Survivin(13 productos)
- TNF(92 productos)
- c-RET(51 productos)
- p53(62 productos)
Mostrar 6 subcategorías más
Se han encontrado 5600 productos de "Apoptosis"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
(E)-[6]-Dehydroparadol
CAS:<p>(E)-[6]-Dehydroparadol ((6)-Dehydroparadol), an oxidative metabolite of [6]-Shogaol, is a potent Nrf2 activator.</p>Fórmula:C17H24O3Pureza:99.85%Forma y color:SolidPeso molecular:276.37FAK-IN-5
CAS:<p>FAK-IN-5 is a FAK signaling inhibitor that induces apoptosis and autophagy.</p>Fórmula:C29H29ClF3N3O4Forma y color:SolidPeso molecular:576.01CAY10773
CAS:<p>CAY10773, a sorafenib derivative, inhibits cancer cells over non-cancerous ones and induces apoptosis or ferroptosis in T24 cells.</p>Fórmula:C22H17Cl2N5OForma y color:SolidPeso molecular:438.31FD223
CAS:FD223, a PI3Kδ inhibitor, is highly potent (IC50=1 nM) and selective, limiting AML cell growth by causing G1 arrest.Fórmula:C17H12ClN5O2SForma y color:SolidPeso molecular:385.83SEC
CAS:<p>SEC triggers ANXA7 GTPase via AMPK/mTORC1/STAT3, causing ITGB4-driven apoptosis in ITGB4-high cancer cells.</p>Fórmula:C22H23ClN2O5Forma y color:SolidPeso molecular:430.88MDM2/XIAP-IN-2
CAS:<p>MDM2/XIAP-IN-2 is a dual inhibitor targeting murine double minute 2 (MDM2) and X-linked inhibitor of apoptosis protein (XIAP).</p>Fórmula:C29H32N2O4SForma y color:SolidPeso molecular:504.64S-Gem
CAS:<p>S-Gem, a thioredoxin reductase (TrxR)-dependent prodrug of Gemcitabine, is selectively activated by TrxR.</p>Fórmula:C13H15F2N3O6S2Pureza:98%Forma y color:SolidPeso molecular:411.4RETRA
CAS:<p>RETRA is an agent of anticancer that acts by exerting anticancer activity in Ewing's sarcoma cells independent of their TP53 status.</p>Fórmula:C11H12BrNO3S2Pureza:98%Forma y color:SolidPeso molecular:350.25AMG-548
CAS:<p>AMG-548, oral p38α inhibitor (Ki=0.5 nM), >1000x selectivity over p38γ/δ, blocks TNFα (IC50=3 nM), also inhibits Wnt/Casein kinase 1δ/ε.</p>Fórmula:C29H27N5OPureza:99.91%Forma y color:SolidPeso molecular:461.56p-nitro-Pifithrin-α
CAS:<p>p-nitro-Pifithrin-α is a cell-permeable analog of pifithrin-α, a potent p53 inhibitor.</p>Fórmula:C15H16BrN3O3SForma y color:SolidPeso molecular:398.27MI-63
CAS:<p>MI-63 is a potent, specific, non-peptide inhibitor of the MDM2-p53 interaction.</p>Fórmula:C29H35Cl2FN4O3Forma y color:SolidPeso molecular:577.52Anticancer agent 72
CAS:<p>Compound 8c inhibits K+ channel and induces apoptosis, showing promise as an anticancer agent.</p>Fórmula:C20H19N7O2Forma y color:SolidPeso molecular:389.41Anticancer agent 32
CAS:<p>Compound 2g, an anticancer agent, disrupts cell cycle and induces apoptosis for cancer research.</p>Fórmula:C24H21F2N5OForma y color:SolidPeso molecular:433.45PTG-0861
CAS:<p>PTG-0861 is a selective HDAC6 inhibitor with an IC50 of 5.92 nm, promising for hematological cancer research.</p>Fórmula:C15H9F5N2O3Forma y color:SolidPeso molecular:360.24Antitumor agent-53
CAS:<p>Antitumor agent-53 hinders tumor growth, induces G2/M cell cycle arrest, and triggers apoptosis via PI3K/AKT in HGC-27 cells.</p>Fórmula:C24H18FN3OForma y color:SolidPeso molecular:383.42Perillic acid
CAS:<p>Perillic acid, a perillyl alcohol metabolite, induces lung cancer cell arrest, apoptosis, and has anti-HSV-1 and immune-modulating effects.</p>Fórmula:C10H14O2Forma y color:SolidPeso molecular:166.22AG6033
CAS:<p>AG6033, a novel CRBN modulator, degrades GSPT1/IKZF1 and inhibits various tumors.</p>Fórmula:C30H23N5O4Forma y color:SolidPeso molecular:517.53Antitumor agent-44
CAS:<p>Antitumor agent-44 (Compound 5n) elicits potent antitumor effects by inducing disruption of mitochondrial homeostasis, cell cycle arrest, and apoptosis in human</p>Fórmula:C24H15N3O3Forma y color:SolidPeso molecular:393.39Pim-1 kinase inhibitor 1
CAS:<p>Pim-1 kinase inhibitor 1, IC50 0.11 μM, combats various cancers by inducing apoptosis.</p>Fórmula:C19H13N3O3Forma y color:SolidPeso molecular:331.32E64FC26
CAS:<p>E64FC26 is a PDI family pan-inhibitor with antitumor activity that inhibits PDIA1 and PDIA6 and can be used to study multiple myeloma and pancreatic cancer.</p>Fórmula:C19H23F3O2Pureza:98.1% - 98.1%Forma y color:SolidPeso molecular:340.38CTX1
CAS:<p>CTX1 is a small molecule activator of p53.</p>Fórmula:C14H10N4Pureza:98%Forma y color:SolidPeso molecular:234.26USP7-IN-4
CAS:<p>USP7-IN-4 is a non-competitive, potent and selective inhibitor of USP7, up-regulates p53 and p21, down-regulates MDM2,anti-proliferativity RS4;11 (leukemia) .</p>Fórmula:C29H34N6O3Pureza:98.27% - 99.09%Forma y color:SolidPeso molecular:514.62Anisperimus
CAS:<p>Anisperimus (LF 15-0195) is an immunosuppressant that prevents CNS autoimmunity by promoting the development of regulatory CD4 T cells expressing Foxp3.</p>Fórmula:C18H39N7O3Pureza:98.10%Forma y color:SolidPeso molecular:401.55ABT-100
CAS:<p>ABT-100 is a potent, highly selective, and orally active farnesyl transferase inhibitor with broad-spectrum antitumor activity.</p>Fórmula:C27H19F3N4O3Pureza:98%Forma y color:SolidPeso molecular:504.46Apoptotic agent-3
CAS:<p>"Apoptotic agent-3 targets Bcl-2/Bax, activates caspase-3, and has anti-proliferative properties for cancer research."</p>Fórmula:C31H21N5OSForma y color:SolidPeso molecular:511.6CCT373566
CAS:<p>CCT373566: potent BCL6 degrader, oral, IC50 2.2 nM; hinders cell growth in vitro & shrinks tumors in vivo.</p>Fórmula:C26H29ClF2N6O3Forma y color:SolidPeso molecular:547YLT205
CAS:<p>YLT205 is an inducer of apoptosis in human colorectal cells that acts by inhibiting tumor growth.</p>Fórmula:C16H12BrClN4O2S2Pureza:98%Forma y color:SolidPeso molecular:471.78GL-331
CAS:<p>GL-331, a DNA topoisomerase II inhibitor, is used potentially for the treatment of small cell lung cancer and gastric cancer.</p>Fórmula:C27H24N2O9Forma y color:SolidPeso molecular:520.49MDM2-p53-IN-16
CAS:<p>MDM2-p53-IN-16 inhibits p53/MDM2 complex (IC 50 = 4.3 nM), triggers p53, causes GBM cell apoptosis, useful in cancer research.</p>Fórmula:C32H33N3O5Forma y color:SolidPeso molecular:539.62PI3Kα-IN-6
CAS:<p>PI3Kα-IN-6 (Compound 5b) is a PI3Kα inhibitor that exhibits anticancer effects without toxicity to normal cells.</p>Fórmula:C16H15IN2OSForma y color:SolidPeso molecular:410.27Prexasertib mesylate
CAS:<p>Prexasertib (LY2606368), a Chk1/2 inhibitor, enhances therapy in acute lymphoblastic leukemia, causing DNA damage and antitumor effects.</p>Fórmula:C19H23N7O5SPureza:98%Forma y color:SolidPeso molecular:461.49DNL343
CAS:<p>DNL343 is an eIF2B activator that inhibits stress granule (SG) assembly induced by the C9ORF72 dipeptide repeat.</p>Fórmula:C20H19ClF3N3O4Pureza:99.96%Forma y color:SolidPeso molecular:457.83STAT3-IN-11
CAS:<p>STAT3-IN-11 is a STAT3 inhibitor.STAT3-IN-11 promotes apoptosis in cancer cells and is a candidate compound for the treatment of cancer.</p>Fórmula:C20H17NO4Pureza:98.3%Forma y color:SolidPeso molecular:335.35EGFR-IN-88
CAS:<p>EGFR-IN-88 (Compound 4i), an EGFR inhibitor with an IC50 of 87 nM, exhibits cytotoxic effects on A549 cells at an IC50 of 3.902 μM and can induce cell apoptosis</p>Fórmula:C22H18Cl2N4O2SPureza:98%Forma y color:SolidPeso molecular:473.37ASK1-IN-3
CAS:<p>ASK1-IN-3, selective ASK1 inhibitor with 33.8 nM IC50; inhibits cell cycle kinases; induces apoptosis in HepG2 cells.</p>Fórmula:C18H18N8O2Forma y color:SolidPeso molecular:378.39Verrucarin J
CAS:<p>Verrucarin J, a Myrothecium fungus metabolite, triggers apoptosis in some cancer cells and fights Candida, Mucor, and JUNV (IC50: 1.2 ng/mL).</p>Fórmula:C27H32O8Forma y color:SolidPeso molecular:484.54Sparfosic Acid
CAS:<p>Sparfosic Acid (Acide sparfosique) is an aspartate carbamoyltransferase inhibitor with antitumor activity and can be used to study advanced renal cell carcinoma</p>Fórmula:C6H10NO8PPureza:98.89%Forma y color:SolidPeso molecular:255.12MDM2-IN-1
CAS:<p>MDM2-IN-1 is a synthetic MDM2-p53 interaction (MDM2) inhibitor and contains the trans (D-)configuration.</p>Fórmula:C23H21Cl2FN2O3Forma y color:SolidPeso molecular:463.33VEGFR-2-IN-23
CAS:<p>VEGFR-2-IN-23 (11b) is a potent VEGFR-2 inhibitor with an IC50 of 0.34 nM, exhibits antitumor effects, and causes G1 cell cycle arrest.</p>Fórmula:C22H15N5O2Forma y color:SolidPeso molecular:381.39YH-306
CAS:<p>YH-306 (TRV055 acetate ) is a modulator of the FAK signaling pathway that acts by suppressing colorectal tumor growth and metastasis.</p>Fórmula:C19H18N2O2Pureza:98.06%Forma y color:SolidPeso molecular:306.36HMBPP triammonium
CAS:<p>HMBPP triammonium is a stimulator of gamma delta T cells.</p>Fórmula:C5H15NO8P2Forma y color:SolidPeso molecular:279.122L6H21
CAS:<p>L6H21 is an MD-2 inhibitor that can be used to study cognitive impairment and brain damage.</p>Fórmula:C18H18O4Pureza:99.26%Forma y color:SolidPeso molecular:298.33MCL-1/BCL-2-IN-3
CAS:<p>MCL-1/BCL-2-IN-3 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor with IC50s of 5.95 and 4.78 μM, respectiely.</p>Fórmula:C27H25BrN2O5SForma y color:SolidPeso molecular:569.47PI3Kα-IN-7
CAS:<p>PI3Kα-IN-7 (Compound A12) is a potent PI3Kα inhibitor, and also inhibits PI3Kβ.</p>Fórmula:C17H22N8O2SForma y color:SolidPeso molecular:402.47B-Raf IN 9
CAS:<p>B-Raf IN 9 is a potent B-Raf inhibitor (IC50=24.79 nM), induces G2/M arrest and apoptosis, and inhibits PC-3 prostate cancer cells (IC50=7.83 μM).</p>Fórmula:C23H20N4OSForma y color:SolidPeso molecular:400.5c-Met-IN-9
CAS:<p>c-Met-IN-9 is a 4-phenoxypyridine derivative and a c-Met kinase inhibitor (IC50: 12 nM). c-Met-IN-9 induces apoptosis and shows antitumour effects.</p>Fórmula:C25H19F2N5O3Forma y color:SolidPeso molecular:475.45Apoptosis inducer 6
CAS:<p>Apoptosis inducer 6 is an anticancer agent with broad-spectrum anticancer activity that induces apoptosis, which triggers cell death.</p>Fórmula:C27H26N4O3SForma y color:SolidPeso molecular:486.59TL02-59 dihydrochloride
CAS:<p>TL02-59 dihydrochloride is an orally active inhibitor of Src-family kinase Fgr (IC50: 0.03 nM).</p>Fórmula:C32H36Cl2F3N5O4Pureza:98%Forma y color:SolidPeso molecular:682.56PAK4-IN-2
CAS:<p>PAK4-IN-2 inhibits PAK4 with IC50 2.7 nM, arrests MV4-11 cells at G0/G1, and induces apoptosis, promising for cancer research.</p>Fórmula:C18H21ClN6Forma y color:SolidPeso molecular:356.85PD-1/PD-L1-IN-25
CAS:<p>"PD-1/PD-L1-IN-25 blocks PD-1/PD-L1 (IC50: 16.17 nM), boosting T-cell anti-tumor immunity, useful for cancer research."</p>Fórmula:C26H24ClN3O5Forma y color:SolidPeso molecular:493.94MIR96-IN-1
CAS:<p>MIR96-IN-1 selectively inhibits biogenesis of microRNA-96, upregulating a protein target (FOXO1) and inducing apoptosis in cancer cells.</p>Fórmula:C33H48N8O2Forma y color:SolidPeso molecular:588.79GLS1 Inhibitor-4
CAS:<p>GLS1 Inhibitor-4 (41e) has 11.86 nM IC50, strong binding, disrupts glutamine metabolism, induces apoptosis, and shows antitumor effects.</p>Fórmula:C29H27F3N10O2S2Pureza:98%Forma y color:SolidPeso molecular:668.72PD180970
CAS:<p>PD180970 is an inhibitor of Bcr-Abl with IC50s of 5 nM, 0.8 nM and 50 nM for the autophosphorylation of p210Bcr-Abl, Src and Kit.</p>Fórmula:C21H15Cl2FN4OPureza:98.67%Forma y color:SolidPeso molecular:429.27Epofolate
CAS:<p>Epofolate: folate receptor-targeted antimitotic, delivers epothilone to cancer cells, inhibits mitosis, may halt tumor growth. Check clinical trials.</p>Fórmula:C67H92N16O22S3Forma y color:SolidPeso molecular:1569.74Allethrin
CAS:<p>Allethrin induces oxidative stress, apoptosis and calcium release. Allethrin, a pyrethroid insecticide is a major mosquito repellent agent.</p>Fórmula:C19H26O3Pureza:99.52%Peso molecular:302.41PDPOB
CAS:<p>PDPOB, a phenyl carboxylic acid derivative, may protect neurons from ischemic damage by reducing mitochondrial issues, oxidative stress, and cell death.</p>Fórmula:C15H20O5Forma y color:SolidPeso molecular:280.322,3-DCPE
CAS:<p>Induces p21, S-phase arrest in cancer cells through ERK pathways. IC50: 0.89 μM (LoVo cells), 12.6 μM (fibroblasts).</p>Fórmula:C11H15Cl2NO2Pureza:98%Forma y color:SolidPeso molecular:264.15WJ35435
CAS:<p>WJ35435 is a histone deacetylase and topoisomerase I dual inhibitor.</p>Fórmula:C20H21N3O3Pureza:98%Forma y color:SolidPeso molecular:351.4TRAF-STOP inhibitor 6877002
CAS:<p>TRAF-STOP 6877002 inhibits CD40-TRAF6, curbing leukocyte recruitment and macrophage activation/proliferation in plaques.</p>Fórmula:C17H17NOPureza:99.76%Forma y color:SolidPeso molecular:251.32S130
CAS:<p>S130 is a high affinity, selectiveATG4B (a major cysteine protease) inhibitor (IC50 of 3.24 μM).It suppresses autophagy flux.</p>Fórmula:C24H25N3O2Pureza:98%Forma y color:SolidPeso molecular:387.47Anticancer agent 55
CAS:<p>Potent anticancer agent inhibits cell growth, migration, induces apoptosis; promising for prostate, breast cancer studies.</p>Fórmula:C28H21Br2FN2O2Forma y color:SolidPeso molecular:596.294N1,N11-Diethylnorspermine
CAS:<p>DENSPM: potent anticancer, spurs polyamine breakdown, triggers cytochrome c release and caspase 3, kills GBM via SSAT & H2O2.</p>Fórmula:C13H32N4Forma y color:SolidPeso molecular:244.42CFM 4
CAS:CFM 4 is a potent small molecule CARP-1/APC-2 antagonist that prevents CARP-1 from binding to APC-2, contributes to G2M cell cycle arrest, and induces apoptosisFórmula:C22H16ClN3OSPureza:98.16%Forma y color:SolidPeso molecular:405.9Topoisomerase II inhibitor 9
CAS:<p>Topoisomerase II inhibitor 9: Topo II blocker (IC50: 0.97 μM), DNA intercalator (IC50: 43.51 μM), arrests G2/M in Hep G-2 cells and triggers apoptosis.</p>Fórmula:C22H17N7O3S2Forma y color:SolidPeso molecular:491.55HI5
CAS:<p>HI5: potent tubulin/IDO inhibitor, IC50 70 nM (HeLa), blocks kynurenine, G2/M arrest, spurs T cell activity, & triggers apoptosis.</p>Fórmula:C42H43N5O8Forma y color:SolidPeso molecular:745.82PARP-1-IN-2
CAS:<p>PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity against</p>Fórmula:C22H15Cl2N3O2Pureza:98.82%Forma y color:SolidPeso molecular:424.28MSN-50
CAS:<p>MSN-50, an inhibitor of Bax and Bak oligomerization, inhibits liposome permeabilization, prevents genotoxic cell death and promotes neuroprotection.</p>Fórmula:C36H38BrN3O6Forma y color:SolidPeso molecular:688.61GDP366
CAS:<p>GDP366, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. a dual inhibitor of survivin and Op18.</p>Fórmula:C20H17N5OSPureza:98.78% - 99.84%Forma y color:SolidPeso molecular:375.45Mcl1-IN-9
CAS:<p>Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM.</p>Fórmula:C37H39ClN4O4Pureza:98%Forma y color:SolidPeso molecular:639.18Obatoclax
CAS:<p>Obatoclax (GX15-070), a pan-BCL-2 inhibitor (Ki 220 nM) induces autophagy, degrades cyclin D1, and has anti-cancer/antiparasitic properties.</p>Fórmula:C20H19N3OPureza:99.44%Forma y color:SolidPeso molecular:317.38VU0285655-1
CAS:<p>VU0285655-1, a PLD2 inhibitor, halts PLD2-deficient cell growth and protects against high glucose-induced cell death. Used in diabetic retinopathy research.</p>Fórmula:C25H27N5O2Pureza:99.73%Forma y color:SolidPeso molecular:429.51Necrostatin-7
CAS:<p>Necrostatin-7 (Necrostatin 7) is a necrotic apoptosis inhibitor with cardioprotective effects that inhibits RANK-NFATc1 signaling.</p>Fórmula:C16H10FN5OS2Pureza:98.71%Forma y color:SolidPeso molecular:371.41Flonoltinib
CAS:<p>Flonoltinib (JAK2/FLT3-IN-1) is an orally active and efficient JAK2/FLT3 inhibitor with anti-cancer properties.</p>Fórmula:C25H34FN7OPureza:99.52%Forma y color:SolidPeso molecular:467.585HPP-33
CAS:5HPP-33 is an microtubule-stabilizer with the properties of antiproliferative and antimitotic.Fórmula:C20H21NO3Forma y color:SolidPeso molecular:323.39JS-K
CAS:<p>JS-K is a Nitric oxide donor. It has antiproliferative activity.</p>Fórmula:C13H16N6O8Forma y color:SolidPeso molecular:384.3NKP-1339
CAS:<p>NKP-1339 (IT-139) induces G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway.</p>Fórmula:C14H12Cl4N4NaRuPureza:98%Forma y color:SolidPeso molecular:502.14HBV-IN-23
CAS:<p>HBV-IN-23: HBV replication inhibitor, IC50 0.58μM, affects resistant strains, induces HepG2 apoptosis, anti-HCC.</p>Fórmula:C25H27N3O3SForma y color:SolidPeso molecular:449.57Nec-3a
CAS:<p>Nec-3a, an analogue of Necrostatin-3, acts as a RIP1 inhibitor with an inhibition concentration (IC50) of 0.44 μM.</p>Fórmula:C21H18F4N2O4Forma y color:SolidPeso molecular:438.37DAT-230
CAS:<p>DAT-230 is a microtubule inhibitor effective against cancer cells, causing cell cycle arrest and apoptosis via caspase activation.</p>Fórmula:C20H21NO2SForma y color:SolidPeso molecular:339.45MSN-125
CAS:<p>MSN-125 inhibits Bax/Bak apoptosis, protects neurons, prevents MOMP with IC50 of 4μM.</p>Fórmula:C36H38BrN3O6Pureza:98%Forma y color:SolidPeso molecular:688.61LOM612
CAS:<p>LOM612 is a potent and specific FOXO relocator FOXO3a reporter protein endogenous FOXO3a and FOXO1 , down-regulates c-Myc and cyclin D1, anti-proliferative.</p>Fórmula:C13H10N2O2SForma y color:SolidPeso molecular:258.3Tubulin polymerization-IN-13
CAS:<p>Compound 4f inhibits tubulin polymerization (IC50: 0.37 μM), induces apoptosis, and has notable anti-cancer properties.</p>Fórmula:C20H21NO6Forma y color:SolidPeso molecular:371.38LWG-301
<p>LWG-301, a GLS1 allosteric inhibitor, IC50 7 nM, impedes glutamine metabolism and prompts apoptosis; shows antitumor effects.</p>Fórmula:C28H38N8O3SForma y color:SolidPeso molecular:566.72GKK1032B
CAS:<p>GKK1032B: antiproliferative, antibacterial, halts HeLa S3, MCF-7, Vero cells, B. subtilis, M. tuberculosis.</p>Fórmula:C32H39NO4Forma y color:SolidPeso molecular:501.66ARN5187 trihydrochloride
CAS:<p>ARN5187 trihydrochloride: a REV-ERBβ inhibitor that blocks transcription, autophagy, and induces apoptosis with lysosomal cytotoxicity.</p>Fórmula:C24H35Cl3FN3OForma y color:SolidPeso molecular:506.912αβ-Tubulin-IN-1
CAS:<p>αβ-Tubulin-IN-1 is a potent and orally active inhibitor of αβ-Tubulin.</p>Fórmula:C25H19N3O3Forma y color:SolidPeso molecular:409.44ZMF-10
CAS:<p>ZMF-10 inhibits PAK1 (IC50: 174 nM), PAK2, PAK3; affects apoptosis, ER stress, migration in cancer studies.</p>Fórmula:C19H17F6N7OForma y color:SolidPeso molecular:473.38MMP-9-IN-3
CAS:<p>MMP-9-IN-3: MMP-9/AKT inhibitor (IC50: 5.56/2.11 nM), forms H-bonds, cytotoxic, induces apoptosis, used in cancer research.</p>Fórmula:C29H25N3O4Forma y color:SolidPeso molecular:479.53OXPHOS-IN-1
CAS:<p>OXPHOS-IN-1 inhibits oxidative phosphorylation; halts MIA PaCa-2 (IC50: 2.34 μM) and BxPC-3 cells growth (IC50: 13.82 μM).</p>Fórmula:C19H29N3O6S2Forma y color:SolidPeso molecular:459.58EGFR-IN-52
CAS:<p>EGFR-IN-52, a potent EGFR inhibitor, has IC50s: 0.358 μM (wild-type), 86.02 μM (L858R-TK), 432.67 μM (T790M-TK); induces cancer cell apoptosis.</p>Fórmula:C19H18N4O3SForma y color:SolidPeso molecular:382.44SPRC
CAS:<p>"SPRC, a synthetic antioxidant, boosts H2S production, activates STAT3, and guards against doxorubicin heart damage."</p>Fórmula:C6H9NO2SPureza:98%Forma y color:SolidPeso molecular:159.21Autophagy-IN-2
CAS:<p>Autophagy-IN-2 (7h) blocks autophagic flux, triggers cancer cell death, aids in triple-negative breast cancer study.</p>Fórmula:C17H19N5OForma y color:SolidPeso molecular:309.37EGFR-IN-59
CAS:<p>EGFR-IN-59: EGFR inhibitor, IC50 = 190 nM, induces apoptosis, cytotoxic to A549 cells (IC50 = 8.62 μM) and WI38 cells (IC50 = 52.6 μM). Use: Various cancers.</p>Fórmula:C27H23N5O4SForma y color:SolidPeso molecular:513.57Bisindolylmaleimide VIII
CAS:<p>Bisindolylmaleimide VIII (Ro-31-7549) is a selective and highly potent protein kinase C (PKC) inhibitor.</p>Fórmula:C24H22N4O2Pureza:97% - 98.01%Forma y color:SolidPeso molecular:398.46SDZ 224-015
CAS:<p>SDZ 224-015 is an inhibitor of interleukin-1β (IL-1β) converting enzyme and caspase-1 with anti-COVID-19 and anti-inflammatory activity.</p>Fórmula:C30H35Cl2N3O9Pureza:95.49% - 95.49%Forma y color:SolidPeso molecular:652.52RET-IN-12
CAS:<p>RET-IN-12 is a RET inhibitor capable of acting on RET(WT) (IC50: 0.3 nM) and RET(V804M) (IC50: 1 nM).</p>Fórmula:C30H30F3N5O4Forma y color:SolidPeso molecular:581.59CAY10789
CAS:<p>CAY10789: potent CysLT1R antagonist (IC50 2.8 µM), GPBAR1 agonist (EC50 3 µM), reduces U937 cell adhesion, TNF-α, stable with promising pharmacokinetics.</p>Fórmula:C17H15NO2Forma y color:SolidPeso molecular:265.31RET-IN-8
CAS:<p>RET-IN-8 is an inhibitor of rearrangement kinase (RET) during transfection and can be used in cancer research.</p>Fórmula:C27H30N6O3Forma y color:SolidPeso molecular:486.57Sanazole
CAS:<p>Sanazole is a 3-nitrotriazole cpd. It can affect the human cervical cancer cell line.</p>Fórmula:C7H11N5O4Forma y color:SolidPeso molecular:229.19ROC-325
CAS:<p>ROC-325: orally active autophagy inhibitor with anticancer effects, induces kidney cancer cell death; selective action.</p>Fórmula:C28H27ClN4OSPureza:99.26%Forma y color:SolidPeso molecular:503.06PDE5/HDAC-IN-1
CAS:<p>PDE5/HDAC-IN-1 is a potent inhibitor of phosphodiesterase 5 (PDE5) and HDAC, with IC50 values of 46.3 nM and 14.5 nM, respectively.</p>Fórmula:C27H29BrN4O4Forma y color:SolidPeso molecular:553.45DX2-201
CAS:<p>DX2-201 is a potent and selective inhibitor of oxidative phosphorylation (OXPHOS) complex I (IC50: 312 nM) and exhibits anticancer activity.</p>Fórmula:C18H28N2O6S2Forma y color:SolidPeso molecular:432.55JMX0293
<p>JMX0293, a salicylamide derivative, inhibits STAT3, inducing MDA-MB-231 cell apoptosis with IC50=3.38μM, while sparing MCF-10A (IC50>60μM).</p>Fórmula:C25H30Cl2N4O7Forma y color:SolidPeso molecular:569.43Cyclamidomycin
CAS:<p>Cyclamidomycin is an antibiotic. It also functions as an inhibitor of nucleoside diphosphokinase of Escherichia coli.</p>Fórmula:C7H10N2OForma y color:SolidPeso molecular:138.17Rohinitib
CAS:<p>Rohinitib, an eIF4A inhibitor, triggers apoptosis in AML cells and lessens tumor load in models.</p>Fórmula:C29H31NO8Forma y color:SolidPeso molecular:521.56SCAL-255
CAS:<p>SCAL-255 is a mitochondrial complex I (CI) inhibitor, exhibiting potent inhibition with an IC50 of 1.14 μM.</p>Fórmula:C27H28F3N5O3Pureza:98%Forma y color:SolidPeso molecular:527.54MEK-IN-5
CAS:<p>MEK-IN-5: strong MEK inhibitor and NO donor, reduces pMEK/pERK dose/time-dependently, triggers apoptosis in MDA-MB-231 cells.</p>Fórmula:C29H27FN4O10S2Forma y color:SolidPeso molecular:674.67AK301
CAS:<p>AK301 is a potent and selective inhibitor of tubulin polymerization and an effective sensitizer of cancer cells to apoptotic ligands (EC50 < 200 nM).</p>Fórmula:C19H21ClN2O2Pureza:99.27%Forma y color:SolidPeso molecular:344.84YL-939
<p>YL-939 is a potent inhibitor of ferroptosis, targeting the PHB2/ferritin/iron axis to impede this form of cell death.</p>Fórmula:C25H26N6OForma y color:SolidPeso molecular:426.51PSB 0474
CAS:<p>P2Y6 receptor agonist</p>Fórmula:C17H20N2O13P2Pureza:98%Forma y color:SolidPeso molecular:522.29STAT5-IN-2
CAS:<p>STAT5-IN-2 is an inhibitor of STAT5 with antileukemic effects (EC50s: 9 μM and 5 μM in K562 and KU812 cells, respectively).</p>Fórmula:C26H27N3OPureza:99.55%Forma y color:SolidPeso molecular:397.51CDK1/Cyc B-IN-1
CAS:<p>CDK1/Cyc B-IN-1: Potent CDK1/Cyc B inhibitor, IC50 97 nM, induces apoptosis, arrests G2/M cycle, halts cancer growth.</p>Fórmula:C14H12ClN3O2S2Forma y color:SolidPeso molecular:353.85PK9327
CAS:<p>PK9327 is a small-molecule stabilizer that targets cavity-creating p53 cancer mutations.</p>Fórmula:C21H22N2SForma y color:SolidPeso molecular:334.48(5Z,2E)-CU-3
CAS:<p>(5Z,2E)-CU-3 is a potent and selective inhibitor of DGKα isozyme with an IC50 value of 0.6 μM and inhibition of DGKα by competing ATP with a Km value of 0.48 mM</p>Fórmula:C16H12N2O4S3Pureza:99.02%Forma y color:SolidPeso molecular:392.47EGFR-IN-46
CAS:<p>EGFR-IN-46: Potent EGFR/FAK inhibitor (IC50: 20.17 & 14.25 nM), curbs cancer cell growth, triggers apoptosis.</p>Fórmula:C27H32F3N3O3Forma y color:SolidPeso molecular:503.56MMP-9-IN-5
CAS:<p>MMP-9-IN-5: MMP-9 and AKT inhibitor (IC50: 4.49 nM and 1.34 nM), induces apoptosis for cancer research.</p>Fórmula:C27H20IN3O4Forma y color:SolidPeso molecular:577.37PD-1/PD-L1-IN-14
CAS:<p>PD-1/PD-L1-IN-14 (compound 17) is an inhibitor of PD-1/PD-L1 interaction (IC50=27.8 nM).</p>Fórmula:C24H24N4O2Forma y color:SolidPeso molecular:400.47Gemcitabine monophosphate
CAS:<p>R306465, a potent HDAC1/8 inhibitor, has broad antitumor effects (IC50: 30-300 nM) on solid and blood cancers.</p>Fórmula:C9H12F2N3O7PForma y color:SolidPeso molecular:343.18T-3256336
CAS:<p>T-3256336 is an oral IAP blocker targeting cIAP-1, cIAP-2, and XIAP.</p>Fórmula:C31H45F2N5O5Pureza:98%Forma y color:SolidPeso molecular:605.72BTK-IN-9
CAS:<p>BTK-IN-9 reversibly inhibits BTK, disrupts mitochondria, boosts ROS, and triggers apoptosis in Z138 cells, impeding condyloma cell growth.</p>Fórmula:C25H19N7O4Forma y color:SolidPeso molecular:481.46CAY10747
CAS:<p>CAY10747, a celastrol derivative, inhibits Hsp90-Cdc37 interaction, decreases client proteins, and induces apoptosis in various cancer cells.</p>Fórmula:C42H48FNO6Forma y color:SolidPeso molecular:681.83Cinnabarinic acid
CAS:<p>mGlu4 receptor agonist</p>Fórmula:C14H8N2O6Pureza:98%Forma y color:SolidPeso molecular:300.22RIPK1-IN-3
CAS:<p>RIPK1-IN-3 is a RIPK1 inhibitor, with anti-inflammatory proprieties.</p>Fórmula:C22H19F3N6O3Pureza:98%Forma y color:SolidPeso molecular:472.42Anti-inflammatory agent 11
CAS:<p>Potent anti-inflammatory compound 16 combats tuberculosis, inhibiting Mtb H37Rv and M299 (MICs: 1.3, 6.9 μM) and reduces NO, TNF-α, IL-1β production.</p>Fórmula:C14H14N4OSForma y color:SolidPeso molecular:286.35RLX
CAS:RLX (PD 139530) is a PI3K/Akt/FoxO3a signal inhibitor with anticancer,antitussive and anti-asthmatic activity,colon cancer,toxicity toward A549 cells..Fórmula:C13H14N2OPureza:99.81%Forma y color:SolidPeso molecular:214.26SCAL-266
CAS:<p>SCAL-266, a potent inhibitor of mitochondrial complex I (CI), exhibits an IC50 of 0.83 μM.</p>Fórmula:C27H28F3N5O2Pureza:98%Forma y color:SolidPeso molecular:511.54VU0424465
CAS:<p>VU0424465 is a mGlu5-selective allosteric agonist.</p>Fórmula:C19H19FN2O2Forma y color:SolidPeso molecular:326.36AZD 1152 (hydrochloride)
CAS:<p>AZD 1152, an oral prodrug, becomes AZD 1152-HQPA in plasma, selectively inhibits Aurora kinase B (IC50=0.36 nM), and blocks tumor growth.</p>Fórmula:C26H33Cl2FN7O6PForma y color:SolidPeso molecular:660.47SAR125844
CAS:<p>SAR125844, a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK), for intravenous administration. (IC50 value of 4.2 nmol/L)</p>Fórmula:C25H23FN8O2S2Pureza:98.73%Forma y color:SolidPeso molecular:550.63VU 0364739 hydrochloride
CAS:<p>VU 0364739 hydrochloride (VU 0364739 HCl) is a phospholipase D2 (PLD2) inhibitor that induces apoptosis and can be used in cancer research.</p>Fórmula:C26H28ClFN4O2Pureza:99.36%Forma y color:SolidPeso molecular:482.98VEGFR-2/BRAF-IN-2
<p>VEGFR-2/BRAF-IN-2 inhibits VEGFR-2, BRAF V600E, BRAF WT (IC50: 0.111/0.089/0.071 µM); induces G1 arrest and apoptosis.</p>Fórmula:C26H21ClF3N5O3S2Forma y color:SolidPeso molecular:608.05EL-102
CAS:<p>EL-102 is a HIF1α inhibitor with anticancer activity that inhibits microtubule protein polymerization and can be used to study prostate cancer.</p>Fórmula:C19H16N2O3S2Pureza:99.34%Forma y color:SolidPeso molecular:384.47HDAC6-IN-4
CAS:<p>HDAC6-IN-4 (C10), an oral, selective, potent HDAC6 inhibitor with low toxicity, IC50: 23 nM, promotes apoptosis and strong anti-tumor action.</p>Fórmula:C30H38N2O5Forma y color:SolidPeso molecular:506.63Irbesartan HCl
CAS:<p>Irbesartan: angiotensin II blocker; treats hypertension by inhibiting receptor binding.</p>Fórmula:C25H29ClN6OPureza:98%Forma y color:SolidPeso molecular:465p-DDAP
CAS:<p>p-DDAP inhibits cell invasion and reduces MMP-9 activity and expression.</p>Fórmula:C18H31NOPureza:98%Forma y color:SolidPeso molecular:277.44K-7174 dihydrochloride
CAS:<p>K-7174 dihydrochloride is a novel cell adhesion inhibitor; inhibits the expression of vascular cell adhesion molecule-1 (VCAM-1) induced by either IL-1β or TNF-</p>Fórmula:C33H50Cl2N2O6Pureza:99.15%Forma y color:SolidPeso molecular:641.67PARP14 inhibitor H10
CAS:<p>PARP14 inhibitor H10 is a selective inhibitor against PARP14 with IC50 of 490 nM</p>Fórmula:C24H27N7O7SPureza:98%Forma y color:SolidPeso molecular:557.58BN201
CAS:<p>BN201 (OCS-05) is a neuroprotective drug by activating SGK2 and FOXO3 pathway. BN201 is able to regulate multiple kinases in the IGF1 pathway and cross BBB.</p>Fórmula:C25H38FN5O4Pureza:99.42% - 99.42%Forma y color:SolidPeso molecular:491.6HDAC8-IN-3
CAS:<p>HDAC8-IN-3 (P19) inhibits HDAC8 (IC50 9.3 μM), induces leukemic cell apoptosis, and enhances thermal stability.</p>Fórmula:C18H12N4O3S2Forma y color:SolidPeso molecular:396.44BRD0476
CAS:<p>BRD0476 prevents pancreatic β-cell death by blocking IFN-γ-induced JAK2 & STAT1 without inhibiting JAK kinase activity.</p>Fórmula:C35H38N4O8SPureza:98%Forma y color:SolidPeso molecular:674.76Erasin
<p>Erasin is a STAT3 inhibitor induces apoptosis in various cancer cell lines (e.g., MDA-MB-231, HCC-827) and against Erlotinib-resistant cancer cells.</p>Fórmula:C20H19N3O3Forma y color:SolidPeso molecular:349.38PDK4-IN-1
CAS:<p>PDK4-IN-1 is an anthraquinone derivative and a potent and orally active inhibitor of pyruvate dehydrogenase kinase 4 (PDK4)(IC50 value of 84 nM).</p>Fórmula:C22H19N3O2Pureza:98%Forma y color:SolidPeso molecular:357.41CDK8/19-IN-1
CAS:<p>CDK8/19-IN-1 is a selective and oral bioavailable CDK8/19 dual inhibitor (IC50s: 0.46 nM, 0.99 nM, and 270 nM for CDK8, CDK19, and CDK9).</p>Fórmula:C19H18N4O4S2Pureza:98%Forma y color:SolidPeso molecular:430.5Tubulin/MMP-IN-2
CAS:<p>Tubulin/MMP-IN-2 blocks tubulin polymerization, MMP-2/-3/-9, induces apoptosis, aids cancer research, IC50: 24.95, 31.60, 22.37 µM.</p>Fórmula:C40H48NO11PForma y color:SolidPeso molecular:749.78Psammaplysene A
CAS:Psammaplysene A is a FOXO1a nuclear export inhibitor.Fórmula:C27H35Br4N3O3Pureza:98%Forma y color:SolidPeso molecular:769.2VMY-1-103
CAS:<p>VMY-1-103: a strong CDK inhibitor better than purvalanol B; halts prostate/breast cancer cell growth, induces apoptosis, may treat medulloblastoma.</p>Fórmula:C34H42ClN9O4SForma y color:SolidPeso molecular:708.27HJC0416
CAS:<p>HJC0416 is a potent orally bioavailable signal transducer and activator of transcription 3 inhibitor.</p>Fórmula:C18H17ClN2O4SPureza:98%Forma y color:SolidPeso molecular:392.86MYRA-A
CAS:<p>MYRA-A is an inducer of apoptosis in a Myc-dependent manner that acts by inhibiting Myc-driven transformation and disrupting MYC-Max interaction.</p>Fórmula:C19H20N2O4Pureza:98%Forma y color:SolidPeso molecular:340.37RSH-7
CAS:<p>RSH-7 is a potent dual inhibitor of BTK and FLT3, with IC50s of 47 and 12 nM, respectively.RSH-7 has antiproliferative and antitumor activities, inducing</p>Fórmula:C22H25FN8OPureza:98.31%Forma y color:SolidPeso molecular:436.49TPB15
CAS:<p>TPB15, an oral Hh inhibitor, blocks Smo activity, arrests cell cycle, induces apoptosis, and shows potent antitumor effects with low toxicity.</p>Fórmula:C18H9Cl4N5OForma y color:SolidPeso molecular:453.11AP1867
CAS:<p>AP1867 is a synthetic FKBP12F36V-directed ligand.</p>Fórmula:C38H47NO11Forma y color:SolidPeso molecular:693.78Bcl-2/Mcl-1-IN-1
CAS:<p>Bcl-2/Mcl-1-IN-1 is an inhibitor of Bcl-2 (Ki: 4.53 μM) and Mcl-1 (Ki: 1.19 μM).Bcl-2/Mcl-1-IN-1 can be used in cancer research.</p>Fórmula:C28H23NO3Forma y color:SolidPeso molecular:421.49ANO1-IN-3
CAS:<p>ANO1-IN-3 (Compound 3n) can induces apoptosis that is a potent and selective inhibitor of ANO1 with an IC 50 of 1.23 μM [1].</p>Fórmula:C20H17NO3Forma y color:SolidPeso molecular:319.35EGFR/HER2/TS-IN-1
CAS:<p>EGFR/HER2/TS-IN-1 inhibits EGFR (0.203 μM), HER2 (0.088 μM), TS (0.168 μM), and induces apoptosis in MCF7 cells.</p>Fórmula:C24H15N5O4S2Forma y color:SolidPeso molecular:501.54Tezacitabine
CAS:<p>Tezacitabine, a nucleoside analogue, inhibits ribonucleotide reductase, disrupts DNA replication, and induces apoptosis in tumor cells.</p>Fórmula:C10H12FN3O4Forma y color:SolidPeso molecular:257.22PI3K/AKT-IN-2
CAS:<p>PI3K/AKT-IN-2 inhibits PI3K/AKT, EMT, induces apoptosis, and blocks tubulin polymerization.</p>Fórmula:C32H27BrO10Forma y color:SolidPeso molecular:651.45Epirubicin
CAS:<p>Epirubicin, a doxorubicin derivative, is an antineoplastic, inhibits topoisomerase, DNA/RNA synthesis, and Foxp3, reducing T cell activity.</p>Fórmula:C27H29NO11Forma y color:SolidPeso molecular:543.52SLMP53-2
CAS:<p>SLMP53-2 is a mutant p53 reactivator that restores the wild-type-like conformation and DNA-binding ability of mutp53-Y220C through enhanced interaction with</p>Fórmula:C26H22N2O2Forma y color:SolidPeso molecular:394.47LLL3
CAS:<p>LLL3 is a small molecule STAT3 inhibitor.</p>Fórmula:C16H10O4Forma y color:SolidPeso molecular:266.25TNF-α-IN-1
CAS:<p>TNF-α-IN-1 is a TNF-α inhibitor.</p>Fórmula:C16H14ClN3O5Pureza:98.82%Forma y color:SolidPeso molecular:363.75MpsBAY2a
CAS:<p>carcinoma cell proliferation.</p>Fórmula:C29H28N6OPureza:98%Forma y color:SolidPeso molecular:476.57TH1834 dihydrochloride
CAS:<p>TH1834 dihydrochloride is a specific Tip60 histone acetyltransferase inhibitor.</p>Fórmula:C33H42Cl2N6O3Pureza:98%Forma y color:SolidPeso molecular:641.63Luxeptinib
CAS:<p>Luxeptinib (CG-806) is an oral, non-covalent pan-FLT3/BTK inhibitor for acute myeloid leukemia.</p>Fórmula:C25H17F4N5O2Forma y color:SolidPeso molecular:495.43MBM-17
CAS:<p>MBM-17 is a potent inhibitor of NIMA-related kinase 2 (Nek2,IC50 of 3 nM).</p>Fórmula:C28H28N6O2Pureza:98%Forma y color:SolidPeso molecular:480.56MRS 2693 trisodium salt
CAS:<p>MRS 2693 trisodium salt is a P2Y6 agonist.</p>Fórmula:C9H22IN5O12P2Pureza:98%Forma y color:SolidPeso molecular:581.15Apoptotic agent-2
CAS:<p>Apoptotic agent-2 reduces Bcl-2, boosts Bax & caspase-3, inducing apoptosis for cancer research.</p>Fórmula:C25H16ClN7SForma y color:SolidPeso molecular:481.96Caspase-3/7 activator 2
<p>Caspase-3/7 activator 2 triggers apoptosis with tumor selectivity and anti-proliferative properties.</p>Fórmula:C32H34N2O7Forma y color:SolidPeso molecular:558.62NSC 107512
CAS:<p>NSC 107512, a sangivamycin-like molecule, inhibits CDK9, curbing myeloma growth and triggering cell death.</p>Fórmula:C12H16N6O5Forma y color:SolidPeso molecular:324.29KY1022
CAS:<p>KY1022 is a ras destabilizer. KY1022 targets the Wnt/ß-catenin pathway and inhibits development of metastatic colorectal cancer.</p>Fórmula:C17H19N3OSForma y color:SolidPeso molecular:313.42MMP-9-IN-4
CAS:<p>MMP-9-IN-4 inhibits MMP-9 (IC50=7.46nM) and AKT (IC50=8.82nM), induces apoptosis and is used in cancer research.</p>Fórmula:C28H19F3N4O6Forma y color:SolidPeso molecular:564.47Topoisomerase II inhibitor 3
CAS:<p>Acridone-based Topoisomerase II inhibitor 3 targets topo IIα/β (IC50: 0.17μM α, 0.23μM β), causes DNA damage, and induces apoptosis.</p>Fórmula:C18H20N4O4Forma y color:SolidPeso molecular:356.38CEP-40125
CAS:<p>CEP-40125 (RXDX-107) is a DNA alkylating agent for the study of advanced solid tumors.</p>Fórmula:C28H45Cl2N3O2Pureza:98.28%Forma y color:SolidPeso molecular:526.58CCT373567
CAS:<p>CCT373567 is a potent degrader of the transcriptional repressor BCL6 (IC50: 2.9 nM) and exhibits anti-proliferative effects.</p>Fórmula:C26H29ClF2N6O3Forma y color:SolidPeso molecular:547GK563
CAS:<p>GK563, an iPLA2 inhibitor (IC50=1nM), is 22,000x more potent vs. cPLA2 and may reduce β-cell death in type 1 diabetes.</p>Fórmula:C16H22O2Forma y color:SolidPeso molecular:246.34RIP1 kinase inhibitor 6
CAS:<p>RIP1 Kinase Inhibitor 6 is a potent and selective inhibitor of RIP1 kinase, demonstrating inhibitory activity with an IC50 of less than 100 nM in a human R1P1</p>Fórmula:C19H18F2N2O3Pureza:98%Forma y color:SolidPeso molecular:360.35Mps1-IN-5
CAS:<p>Mps1-IN-5: oral Mps1 inhibitor with 29 nM IC50, induces apoptosis, G2/M arrest, and has anti-tumor properties.</p>Fórmula:C24H25N9Forma y color:SolidPeso molecular:439.52Nampt-IN-3
CAS:<p>Nampt-IN-3 simultaneously inhibit nicotinamide phosphoribosyltransferase (NAMPT) and HDAC (IC50s of 31 nM and 55 nM, respectively).</p>Fórmula:C29H25N7O2Pureza:98%Forma y color:SolidPeso molecular:503.55Telomerase-IN-5
CAS:<p>Telomerase-IN-5 is a potent inhibitor of telomerase with antiproliferative properties, and it induces apoptosis [1].</p>Fórmula:C22H20N4OS2Pureza:98%Forma y color:SolidPeso molecular:420.55IHMT-TRK-284
CAS:<p>IHMT-TRK-284: Oral type II TRK inhibitor; targets TRKA, TRKB, TRKC (IC50s: 10.5, 0.7, 2.6 nM); selective and anti-tumor effective.</p>Fórmula:C25H27N7OSForma y color:SolidPeso molecular:473.59KS106
CAS:<p>KS106 inhibits ALDH (1A1: 334 nM, 2: 2137 nM, 3A1: 360 nM), has anti-cancer properties, raises ROS, and promotes aldehyde build-up.</p>Fórmula:C18H15BrF3N3O2SPureza:99.31%Forma y color:SolidPeso molecular:474.3BS-181
CAS:<p>BS-181 is a highly selective CDK7 inhibitor (IC50: 21 nM); >40-fold selective for CDK7 than CDK1/2/4/5/6/9.</p>Fórmula:C22H32N6Pureza:98%Forma y color:SolidPeso molecular:380.53Antiproliferative agent-32
CAS:<p>Antiproliferative agent-32 (Compound 1c) impedes phosphorylation within the PI3K/Akt/mTOR signaling pathway, restrains proliferation of Huh7 and SK-Hep-1 cells</p>Fórmula:C19H15NO2Pureza:98%Forma y color:SolidPeso molecular:289.33Bax activator-1
CAS:<p>Bax activator-1 (compound 106) is a Bax activator. It induces Bax-dependent tumor cell apoptosis[1].</p>Fórmula:C29H36N4O3Forma y color:SolidPeso molecular:488.62Targapremir-210
CAS:<p>Targapremir-210 (TGP-210) is a miRNA-210 (miRNA-210) inhibitor that inhibits pre-miR-210 processing and induces apoptosis in breast cancer cells.</p>Fórmula:C32H36N10O2Pureza:98%Forma y color:SolidPeso molecular:592.69Anticancer agent 58
<p>Anticancer agent 58 targets A549/T24 cell lines; IC50: 0.6/0.7 μM. It triggers apoptosis, ups Ca2+/ROS, and lowers mitochondrial potential.</p>Fórmula:C39H55NO5Forma y color:SolidPeso molecular:617.86GRI977143
CAS:<p>GRI977143: selective LPA2 agonist (EC50=3.3μM), blocks caspases 3/7/8/9, limits DNA fragmentation.</p>Fórmula:C22H17NO4SPureza:98.07%Forma y color:SolidPeso molecular:391.44FKGK 18
CAS:<p>FKGK 18: GVIA iPLA2 inhibitor, 99.9% at 0.091 fraction, selective, IC50 ~50 nM–3 μM, reduces blood glucose and diabetes in NOD mice.</p>Fórmula:C16H15F3OForma y color:SolidPeso molecular:280.28CCT128930
CAS:<p>'CCT128930, potent Akt2 inhibitor (IC50=6 nM), 28x more selective over PKA.'</p>Fórmula:C18H20ClN5Pureza:99.07% - 99.18%Forma y color:SolidPeso molecular:341.84Justicidin B
CAS:<p>Justicidin B: anticancer, proapoptotic, inhibits bone resorption & platelets, antiviral, fungicidal, antiprotozoal.</p>Fórmula:C21H16O6Forma y color:SolidPeso molecular:364.35PI3Kδ/γ-IN-3
CAS:<p>PI3Kδ/γ-IN-3 (Compound 58) is an orally active dual inhibitor of PI3Kδ (IC50: 1 nM) and PI3Kγ (IC50: 16 nM).</p>Fórmula:C23H20ClN9OForma y color:SolidPeso molecular:473.92SZM-1209
CAS:<p>SZM-1209 is a potent and specific RIPK1 inhibitor with oral activity, displaying a dissociation constant (Kd) of 85 nM.</p>Fórmula:C31H29F5N4O5S2Pureza:98%Forma y color:SolidPeso molecular:696.71VRT-043198
CAS:<p>VRT-043198, a VX-765 metabolite, is a potent ICE/caspase-1 inhibitor, crossing the blood-brain barrier with K i of 0.8/0.6 nM.</p>Fórmula:C22H29ClN4O6Forma y color:SolidPeso molecular:480.94ACA-28
CAS:<p>ACA-28 is an ERK MAPK signalling modulator that induces apoptosis in melanoma cells by overexpressing ERK.</p>Fórmula:C17H16O6Pureza:98.73%Forma y color:SolidPeso molecular:316.31CAM 833
CAS:<p>CAM 833 inhibits BRCA2-RAD51 interaction; Kd for ChimRAD51 is 366 nM, disrupts RAD51 oligocoagulation, and induces apoptosis in G2/M cells.</p>Fórmula:C26H26ClFN4O5Pureza:99.83%Forma y color:SolidPeso molecular:528.96CU-3
CAS:<p>CU-3 inhibits DGKalpha, reducing cancer growth and boosting anti-cancer immunity.</p>Fórmula:C16H12N2O4S3Pureza:98%Forma y color:SolidPeso molecular:392.47Anti-inflammatory agent 17
CAS:<p>Compound 17: Orally active, potent IL-6 & TNF-α inhibitor; not cytotoxic; promising for ALI research.</p>Fórmula:C20H23NO5Forma y color:SolidPeso molecular:357.4DRAK1/2-IN-1
CAS:<p>DRAK1/2-IN-1 is a potent inhibitor targeting both DRAK1 and DRAK2, displaying dissociation constants (Kd) of 1 µM and 6 µM, respectively.</p>Fórmula:C22H24N2O3SForma y color:SolidPeso molecular:396.5ISC-4
CAS:<p>ISC-4 is an Akt inhibitor, which activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.</p>Fórmula:C11H13NSeForma y color:SolidPeso molecular:238.19PD-1-IN-18
CAS:<p>PD-1-IN-18 is a PD1 inhibitor of signaling pathway, and acts as an immunomodulator.</p>Fórmula:C11H17N5O8Pureza:98%Forma y color:SolidPeso molecular:347.28

